{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:21:44Z","timestamp":1791343304236,"version":"4.3.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.jaci.2008.12.024","type":"journal-article","created":{"date-parts":[[2009,2,8]],"date-time":"2009-02-08T04:19:58Z","timestamp":1234066798000},"page":"459-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy"],"prefix":"10.1016","volume":"123","author":[{"given":"Christina L.","family":"Nance","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Siwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Shearer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2008.12.024_bib1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody","volume":"393","author":"Kwong","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2008.12.024_bib2","doi-asserted-by":"crossref","first-page":"30745","DOI":"10.1074\/jbc.M804112200","article-title":"CCL2 increases X4-tropic HIV-1 entry into resting CD4+ T cells","volume":"283","author":"Campbell","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2008.12.024_bib3","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1172\/JCI34706","article-title":"The spread, treatment, and prevention of HIV-1: evolution of a global pandemic","volume":"118","author":"Cohen","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2008.12.024_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jep.2008.01.037","article-title":"Anti-HIV-1 activities of compounds isolated from the medicinal plant Rhus chinensis","volume":"117","author":"Wang","year":"2008","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jaci.2008.12.024_bib5","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/S0960-894X(03)00197-5","article-title":"Anti-AIDS agents 54: a potent anti-HIV chalcone and flavonoids from genus Desmos","volume":"13","author":"Wu","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jaci.2008.12.024_bib6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1021\/np034016p","article-title":"Plant substances as anti-HIV agents selected according to their putative mechanism of action","volume":"67","author":"Cos","year":"2004","journal-title":"J Nat Prod"},{"key":"10.1016\/j.jaci.2008.12.024_bib7","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jaci.2006.08.016","article-title":"Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy","volume":"118","author":"Williamson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2008.12.024_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0163-7258(02)00298-X","article-title":"The biochemistry and medical significance of the flavonoids","volume":"96","author":"Havsteen","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jaci.2008.12.024_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4067\/S0716-97602002000300016","article-title":"Grape seed extract proanthocyanidins downregulate HIV-1 entry coreceptors, CCR2b, CCR3 and CCR5 gene expression by normal peripheral blood mononuclear cells","volume":"35","author":"Nair","year":"2002","journal-title":"Biol Res"},{"key":"10.1016\/j.jaci.2008.12.024_bib10","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1093\/jn\/131.9.2248","article-title":"Theaflavins in black tera and catechins in green tea are equally effective antioxidants","volume":"131","author":"Leung","year":"2001","journal-title":"J Nutr"},{"key":"10.1016\/j.jaci.2008.12.024_bib11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.canlet.2005.10.021","article-title":"Dual function of (-)-epigallocatechin gallate (EGCG) in healthy human lymphocytes","volume":"241","author":"Kanadzu","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jaci.2008.12.024_bib12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbagen.2005.02.012","article-title":"Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41","volume":"1723","author":"Liu","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2008.12.024_bib13","first-page":"393","article-title":"Analysis of plasma and urinary tea polyphenols in human subjects","volume":"4","author":"Lee","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaci.2008.12.024_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0027-5107(02)00336-6","article-title":"Cancer chemopreventive activity and bioavailability of tea and tea polyphenols","volume":"523-524","author":"Lambert","year":"2003","journal-title":"Mutat Res"},{"key":"10.1016\/j.jaci.2008.12.024_bib15","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.4049\/jimmunol.170.8.4335","article-title":"Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis","volume":"170","author":"Dona","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2008.12.024_bib16","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1021\/jf0355194","article-title":"Inhibitory effect of (-)-epigallocatechin 3-gallate, a polyphenol of green tea, on neutrophil chemotaxis in vitro and in vivo","volume":"52","author":"Takano","year":"2004","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.jaci.2008.12.024_bib17","first-page":"278","article-title":"The green tea extract epigallocatechin gallate is able to reduce neutrophil transmigration through monolayers of endothelial cells","volume":"111","author":"Hofbauer","year":"1999","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jaci.2008.12.024_bib18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1006\/bbrc.2000.3200","article-title":"Epigallocatechin gallate inhibits histamine relase from rat basophilic leukemia (RBL-2H3) cells: role of tyrosine phosphorylation pathway","volume":"274","author":"Yamashita","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaci.2008.12.024_bib19","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1021\/jf000313d","article-title":"Inhibitory effects of tea catechins and O-methylated derivatives of (-)-epigallocatechin-3-O-gallate on mouse type IV allergy","volume":"48","author":"Suzuki","year":"2000","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.jaci.2008.12.024_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.antiviral.2007.11.011","article-title":"Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro","volume":"78","author":"Xu","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jaci.2008.12.024_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2005.06.010","article-title":"Antiviral effect of catechins in green tea on influenza virus","volume":"68","author":"Song","year":"2005","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jaci.2008.12.024_bib22","doi-asserted-by":"crossref","first-page":"3262S","DOI":"10.1093\/jn\/133.10.3262S","article-title":"Mechanisms of cancer prevention by tea constituents","volume":"133","author":"Lambert","year":"2003","journal-title":"J Nutr"},{"key":"10.1016\/j.jaci.2008.12.024_bib23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/00002030-200204120-00020","article-title":"Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent","volume":"16","author":"Fassina","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jaci.2008.12.024_bib24","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0091-6749(03)02007-4","article-title":"Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding","volume":"112","author":"Kawai","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2008.12.024_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0166-3542(01)00189-9","article-title":"Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1)","volume":"53","author":"Yamaguchi","year":"2002","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jaci.2008.12.024_bib26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1067\/mai.2000.105315","article-title":"gp120- and TNF-alpha-induced modulation of human B cell function: proliferation, cyclic AMP generation, Ig production, and B-cell receptor expression","volume":"105","author":"Patke","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2008.12.024_bib27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ptr.1629","article-title":"Naturally derived anti-HIV agents","volume":"19","author":"Asres","year":"2005","journal-title":"Phytother Res"},{"key":"10.1016\/j.jaci.2008.12.024_bib28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/1098-1128(200009)20:5<323::AID-MED1>3.0.CO;2-A","article-title":"Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection","volume":"20","author":"De Clercq","year":"2000","journal-title":"Med Res Rev"},{"key":"10.1016\/j.jaci.2008.12.024_bib29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1021\/ol007000o","article-title":"Synthesis of a 3,4,5-trimethoxybenzoyl ester analogue of epigallocatechin-3-gallate (EGCG): a potential route to the natural product green tea catechin, EGCG","volume":"3","author":"Zaveri","year":"2001","journal-title":"Org Lett"},{"key":"10.1016\/j.jaci.2008.12.024_bib30","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/512682","article-title":"HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads","volume":"195","author":"Baeten","year":"2007","journal-title":"J Infect Dis"},{"issue":"suppl 3","key":"10.1016\/j.jaci.2008.12.024_bib31","first-page":"S31","article-title":"Understanding the genetic diversity of HIV-1","volume":"14","author":"McCutchan","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jaci.2008.12.024_bib32","unstructured":"UNAIDS, WHO UNAIDS\/WHO epidemiological fact sheets on HIV\/AIDS and sexually transmitted diseases, 2009 update Available at: http:\/\/www.who.int\/hiv\/pub\/epidemiology\/pubfacts\/en\/. 2009."},{"key":"10.1016\/j.jaci.2008.12.024_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/157016207779316297","article-title":"HIV genetic diversity: biological and public health consequences","volume":"5","author":"Butler","year":"2007","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.jaci.2008.12.024_bib34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tiv.2004.09.001","article-title":"Differential in vitro cytotoxicity of (-)-epicatechin gallate (ECG) to cancer and normal cells from the human oral cavity","volume":"19","author":"Babich","year":"2005","journal-title":"Toxicol in Vitro"},{"key":"10.1016\/j.jaci.2008.12.024_bib35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1006\/abbi.2000.1742","article-title":"Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor \u03baB in cancer cells versus normal cells","volume":"376","author":"Ahmad","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jaci.2008.12.024_bib36","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/0192-0561(92)90011-9","article-title":"Mitogenic activity of (-) epigallocatechin gallate on B-cells and investigation of its structure-function relationship","volume":"14","author":"Hu","year":"1992","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.jaci.2008.12.024_bib37","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood-2006-05-022814","article-title":"Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biological activity and therapeutic implications","volume":"108","author":"Shammas","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2008.12.024_bib38","first-page":"735","article-title":"Evaluation of proteasome-inhibitory and apoptosis-inducing potencies of novel (-)-EGCG analogs and their prodrugs","volume":"15","author":"Landis-Piwowar","year":"2005","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jaci.2008.12.024_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1158\/1535-7163.81.4.1","article-title":"Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation","volume":"4","author":"Roy","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jaci.2008.12.024_bib40","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1158\/0008-5472.CAN-05-3636","article-title":"Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate","volume":"66","author":"Khan","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaci.2008.12.024_bib41","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jaci.2004.10.005","article-title":"Epigallocatechin gallate induces apoptosis of monocytes","volume":"115","author":"Kawai","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2008.12.024_bib42","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.4049\/jimmunol.173.9.5794","article-title":"Green tea Epigallocatechin-3-gallate mediates T cellular NF-kB inhibition and exerts neuroprotection in autoimmune encephalomyelitis","volume":"173","author":"Aktas","year":"2004","journal-title":"J Immunology"},{"key":"10.1016\/j.jaci.2008.12.024_bib43","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.bbrc.2007.08.079","article-title":"Induction of apoptosis by epigallocatechin-3-gallate in human lymphoblastoid B cells","volume":"362","author":"Noda","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaci.2008.12.024_bib44","first-page":"53","article-title":"Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E","volume":"10","author":"Chow","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaci.2008.12.024_bib45","first-page":"3312","article-title":"Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals","volume":"9","author":"Chow","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaci.2008.12.024_bib46","doi-asserted-by":"crossref","first-page":"S582","DOI":"10.1067\/mai.2003.91","article-title":"HIV-1 infection","volume":"111","author":"Sleasman","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2008.12.024_bib47","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1158\/1078-0432.CCR-04-2549","article-title":"Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals","volume":"11","author":"Chow","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaci.2008.12.024_bib48","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/147323000303100205","article-title":"A single ascending dose study of epigallocatechin gallate in healthy volunteers","volume":"31","author":"Ullman","year":"2003","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jaci.2008.12.024_bib49","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/0008-5472.CAN-05-1145","article-title":"Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study","volume":"66","author":"Bettuzzi","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaci.2008.12.024_bib50","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1124\/dmd.104.000083","article-title":"Green tea (Camellia sinensis) extract does not alter cytochrome P450 3A4 or 2D6 activity in healthy volunteers","volume":"32","author":"Donovan","year":"2004","journal-title":"Drug Metab Dispos"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674908024408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674908024408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:16:40Z","timestamp":1758788200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674908024408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0091674908024408"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2008.12.024","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2008.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}